ALB 127158A

Drug Profile

ALB 127158A

Alternative Names: ALB-127158(a)

Latest Information Update: 05 Oct 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AMRI
  • Class Obesity therapies; Small molecules
  • Mechanism of Action MCHR1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 03 Oct 2011 Discontinued - Phase-I for Obesity in United Kingdom (PO)
  • 03 Oct 2011 Final pharmacokinetics, adverse events and efficacy data from two phase I trials in healthy volunteers and patients with Obesity released by AMRI
  • 01 Jun 2011 Topline adverse events and preliminary efficacy data from a phase I trial in volunteers released by AMRI
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top